Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Wagner

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Urologic Oncology|May 16, 2021
The impact of pretreatment PSA on risk stratification in men with Gleason 6 prostate cancer: Implications for active surveillanceSina Monfared, Aaron Fleishman, Ruslan Korets, et al.
Prenatal Diagnosis|October 10, 2013
No evidence for mutations in NLRP7 and KHDC3L in women with androgenetic hydatidiform molesSangeetha Mahadevan, Shu Wen, Alfred Balasa, et al.
Fungal Genetics and Biology : FG & B|July 28, 2004
New information on the mechanism of forcible ascospore discharge from Ascobolus immersusMark Fischer, Justin Cox, Diana J Davis, et al.
Molecular Cytogenetics|September 18, 2020
<i>De novo</i> mosaic and partial monosomy of chromosome 21 in a case with superior vena cava duplicationAbul Kalam Azad, Lindsay Yanakakis, Samantha Issleb, et al.
Urology|June 26, 2026
Extended versus Standard Lymph Node Dissection at the Time of Radical Cystectomy for Bladder CancerJamil Almohtasib, Emily Scire, Sumedh Kaul, et al.
Urologic Oncology|December 1, 2022
Disparities in the prevalence and management of high-risk non-muscle invasive bladder cancerAngela Estevez, Sumedh Kaul, Aaron Fleishman, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
STAT1 Promotes PD-L1 Activation and Tumor Growth in LymphangioleiomyomatosisTasnim Olatoke, Erik Y Zhang, Andrew Wagner, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 17, 2025
Contemporary outcomes and disease burden of high-grade T1 bladder cancerAgustin Perez-Londoño, Sumedh Kaul, Aaron Fleishman, et al.
Prostate Cancer and Prostatic Diseases|March 30, 2024
The association of patient and disease characteristics with the overtreatment of low-risk prostate cancer from 2010 to 2016Cooper Desmond, Sumedh Kaul, Aaron Fleishman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 1, 2012
Evaluation of six proton pump inhibitors as inhibitors of various human cytochromes P450: focus on cytochrome P450 2C19Tatyana Zvyaga, Shu-Ying Chang, Cliff Chen, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Urologic Oncology|May 16, 2021
The impact of pretreatment PSA on risk stratification in men with Gleason 6 prostate cancer: Implications for active surveillanceSina Monfared, Aaron Fleishman, Ruslan Korets, et al.
Prenatal Diagnosis|October 10, 2013
No evidence for mutations in NLRP7 and KHDC3L in women with androgenetic hydatidiform molesSangeetha Mahadevan, Shu Wen, Alfred Balasa, et al.
Fungal Genetics and Biology : FG & B|July 28, 2004
New information on the mechanism of forcible ascospore discharge from Ascobolus immersusMark Fischer, Justin Cox, Diana J Davis, et al.
Molecular Cytogenetics|September 18, 2020
<i>De novo</i> mosaic and partial monosomy of chromosome 21 in a case with superior vena cava duplicationAbul Kalam Azad, Lindsay Yanakakis, Samantha Issleb, et al.
Urology|June 26, 2026
Extended versus Standard Lymph Node Dissection at the Time of Radical Cystectomy for Bladder CancerJamil Almohtasib, Emily Scire, Sumedh Kaul, et al.
Urologic Oncology|December 1, 2022
Disparities in the prevalence and management of high-risk non-muscle invasive bladder cancerAngela Estevez, Sumedh Kaul, Aaron Fleishman, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
STAT1 Promotes PD-L1 Activation and Tumor Growth in LymphangioleiomyomatosisTasnim Olatoke, Erik Y Zhang, Andrew Wagner, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 17, 2025
Contemporary outcomes and disease burden of high-grade T1 bladder cancerAgustin Perez-Londoño, Sumedh Kaul, Aaron Fleishman, et al.
Prostate Cancer and Prostatic Diseases|March 30, 2024
The association of patient and disease characteristics with the overtreatment of low-risk prostate cancer from 2010 to 2016Cooper Desmond, Sumedh Kaul, Aaron Fleishman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 1, 2012
Evaluation of six proton pump inhibitors as inhibitors of various human cytochromes P450: focus on cytochrome P450 2C19Tatyana Zvyaga, Shu-Ying Chang, Cliff Chen, et al.
Pageof 7